Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectio...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/056c3d19e1884cb39886c2ace9ea5564 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:056c3d19e1884cb39886c2ace9ea5564 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:056c3d19e1884cb39886c2ace9ea55642021-12-02T11:40:15ZNasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey10.1038/s41598-018-21837-52045-2322https://doaj.org/article/056c3d19e1884cb39886c2ace9ea55642018-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-21837-5https://doaj.org/toc/2045-2322Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectional study, we obtained data on demography, clinical history, risk factors, and took NP swabs for pneumococcal culture. We calculated crude and age-standardised carriage prevalence and used log-binomial regression to assess risk factors for carriage. Among children aged <5 years, 92% (95% CI: 88–95%) and 78% (73–82%), respectively, carried any pneumococcus and 48% and 50%, respectively, carried PCV10 serotypes. In Kumbotso, carriage prevalence was >40% across all ages. The age-standardized prevalence of pneumococcal carriage was 66% in Kumbotso and 40% in Pakoto. The most commonly identified serotypes were 19 F, 6 A and 23 F. Risk factors for carriage were young age, recent rhinorrhoea, cohabitation with ≥2 children aged <5 years, and sharing a bed with ≥2 persons. Pneumococcal carriage prevalence is high in this Nigerian population. Persisting prevalence of VT-carriage in older children and adults suggests that PCV10 introduction in children will not eliminate transmission of vaccine serotypes rapidly. High vaccine coverage will therefore be required to ensure full protection of children.Ifedayo M. O. AdetifaAishatu L. AdamuAngela KaraniMichael WaithakaKofo A. OdeyemiChristy A. N. OkoromahMohammed M. BelloIsa S. AbubakarVictor InemJ. Anthony. G. ScottNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ifedayo M. O. Adetifa Aishatu L. Adamu Angela Karani Michael Waithaka Kofo A. Odeyemi Christy A. N. Okoromah Mohammed M. Bello Isa S. Abubakar Victor Inem J. Anthony. G. Scott Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
description |
Abstract Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectional study, we obtained data on demography, clinical history, risk factors, and took NP swabs for pneumococcal culture. We calculated crude and age-standardised carriage prevalence and used log-binomial regression to assess risk factors for carriage. Among children aged <5 years, 92% (95% CI: 88–95%) and 78% (73–82%), respectively, carried any pneumococcus and 48% and 50%, respectively, carried PCV10 serotypes. In Kumbotso, carriage prevalence was >40% across all ages. The age-standardized prevalence of pneumococcal carriage was 66% in Kumbotso and 40% in Pakoto. The most commonly identified serotypes were 19 F, 6 A and 23 F. Risk factors for carriage were young age, recent rhinorrhoea, cohabitation with ≥2 children aged <5 years, and sharing a bed with ≥2 persons. Pneumococcal carriage prevalence is high in this Nigerian population. Persisting prevalence of VT-carriage in older children and adults suggests that PCV10 introduction in children will not eliminate transmission of vaccine serotypes rapidly. High vaccine coverage will therefore be required to ensure full protection of children. |
format |
article |
author |
Ifedayo M. O. Adetifa Aishatu L. Adamu Angela Karani Michael Waithaka Kofo A. Odeyemi Christy A. N. Okoromah Mohammed M. Bello Isa S. Abubakar Victor Inem J. Anthony. G. Scott |
author_facet |
Ifedayo M. O. Adetifa Aishatu L. Adamu Angela Karani Michael Waithaka Kofo A. Odeyemi Christy A. N. Okoromah Mohammed M. Bello Isa S. Abubakar Victor Inem J. Anthony. G. Scott |
author_sort |
Ifedayo M. O. Adetifa |
title |
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
title_short |
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
title_full |
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
title_fullStr |
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
title_full_unstemmed |
Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey |
title_sort |
nasopharyngeal pneumococcal carriage in nigeria: a two-site, population-based survey |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/056c3d19e1884cb39886c2ace9ea5564 |
work_keys_str_mv |
AT ifedayomoadetifa nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT aishatuladamu nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT angelakarani nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT michaelwaithaka nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT kofoaodeyemi nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT christyanokoromah nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT mohammedmbello nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT isasabubakar nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT victorinem nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey AT janthonygscott nasopharyngealpneumococcalcarriageinnigeriaatwositepopulationbasedsurvey |
_version_ |
1718395622152732672 |